Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy
Quality of life as measured by FACT-ES and EORTC QLQ C30 tools is similar for patients with early and metastatic hormone receptors-positive breast cancer r